0
This page details the impacts of the philanthropic donations of our incredible donor community, and how it has shaped childhood cancer research in years' past.
The translational research pipeline is the journey of turning discoveries made in the laboratory into new treatments, technologies and models of care that improve outcomes for children with cancer.
The Kids' Cancer Project invests across every stage of this pipeline – from early discovery research and proof-of-concept studies to clinical trials and survivorship research – helping ensure promising ideas don't stall before reaching patients.
By funding innovative science, supporting national research collaborations and investing in the infrastructure needed to translate discoveries into practice, the charity helps accelerate the pathway from breakthrough to bedside, bringing safer, more effective treatments to children sooner.
Co-funding has enabled The Kids’ Cancer Project to back larger, more ambitious research projects than would be possible through donor funding alone, significantly increasing the reach and impact of every dollar invested.
By partnering with organisations including the Australian Government's Medical Research Future Fund (MRFF), state-based cancer foundations and other philanthropic funders, The Kids’ Cancer Project has helped to generate millions of additional dollars into childhood cancer research, supporting more projects, more researchers and greater national collaboration. This collaborative approach has accelerated access to clinical trials, strengthened Australia's childhood cancer research capability and enabled investment in innovative research spanning precision medicine, survivorship and novel therapies that may otherwise have remained unfunded.
